Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection.

Marchbanks CR, McKiel JR, Gilbert DH, Robillard NJ, Painter B, Zinner SH, Dudley MN. Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection. Antimicrob Agents Chemother. 1993 Sep; 37(9):1756-63.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.